Recombinant human erythropoietin promotes the acquisition of a malignant phenotype in head and neck squamous cell carcinoma cell lines in vitro

BACKGROUND: Recent studies indicate an increase in tumor progression and recurrence in head and neck squamous cell carcinomas (HNSCC) of cancer patients taking recombinant human erythropoietin (rhEpo) for anemia. This study was undertaken to investigate the potential role of rhEpo in invasion, proli...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Abhold, Eric, Rahimy, Elham, Wang-Rodriguez, Jessica, Blair, Katherine J, Yu, Michael A, Brumund, Kevin T, Weisman, Robert A, Ongkeko, Weg M
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2011
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3285115/
https://ncbi.nlm.nih.gov/pubmed/22188703
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1756-0500-4-553
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak